The EU sets limited conditions, to accelerate the development of a Corona vaccine. Like the Council, the member States announced on Tuesday evening, will be tested from next Saturday on Covid-19-medicinal products containing genetically modified organisms (GMOs) without prior environmental impact assessment clinically. In addition, it is clarified that the scheme shall also apply if member States want to allow the use of not yet been officially approved Covid-19-medicinal products containing genetically modified organisms.
the Federal health Minister, Jens Spahn (CDU), commented: “This regulation will ensure that clinical trials can start in the EU without delay, and that no valuable time is lost.” A vaccine against Covid-19 will be urgently needed.
The new EU regulation applies, as long as the world health organization Covid-19 regarded as a pandemic, or as long as a decision of the Commission is that she has a health crisis situation due to Covid-19.